Non-Invasive Determination of Breslow Index by Amouroux Marine & Blondel Walter
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Determination of Breslow Index 
Amouroux Marine and Blondel Walter 
Centre de Recherche en Automatique de Nancy (CRAN)  
UMR 7039 CNRS – Nancy University,  
2 avenue de la Forêt de Haye, 54516 Vandoeuvre-lès-Nancy cedex 
France 
 
1. Introduction  
1.1 Current melanoma diagnosis 
1.1.1 Histopathology is the current gold standard technique of melanoma diagnosis 
Although histopathologic examination remains the gold standard for cancer diagnosis, 
melanoma has the potential to be diagnosed through noninvasive approaches because of its 
cutaneous location (Rigel, Russak et al. 2010). Whenever a suspicious skin lesion is removed 
a histological examination is warranted (Garbe, Peris et al. 2009). The histopathologic report 
should include the following information (Ruiter, Spatz et al. 2002): 
- Diagnosis and clinicopathologic type; when there is uncertainty about malignancy it 
should be clearly stated in the report conclusion, 
- Tumour thickness in mm (Breslow depth), 
- Presence or absence of ulceration, 
- Level of invasion (Clark level), especially for thin melanomas <1mm in thickness, 
- Microsatellites (if present), and 
- Lateral and deep excision margins. 
Besides these absolutely necessary histologic features, additional informations can be 
provided, including: 
- Number of mitoses per mm2 (in hot spots). The mitotic activity can inform about the 
risk of relapse and, in some series, the probability of sentinel node positivity, 
- Growth phase (horizontal or vertical), 
- Presence or absence of established regression, 
- Presence or absence of a dense tumour infiltrating lymphocytes (TIL) infiltrate, 
- Lymphatic emboli, and 
- Vascular or perineural involvement. 
In some instances, when the histologic diagnosis is unclear, immunohistochemical stains 
may be helpful (i.e. S-100 protein, HMB45 and Melan-A for the confirmation of the 
melanocytic nature of the tumour, HMB45 as an additional feature of malignancy when 
there is an inverted positive gradient, MIB-1 as a proliferation marker). It is advised to use 
standardised pathology worksheets. An example of such a standardised pathology worksheet 
can be downloaded at www.melanomagroup.eu. 
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1.1.2 American Joint Committee on Cancer (AJCC) Tumor-Node-Metastasis (TNM) 
classification of melanomas 
Tables 1 and 2 display most recent (2009) classification as well as clinical and pathological 
staging recommended by the American Joint Committee on Cancer (AJCC) (Balch, 
Gershenwald et al. 2009). 
 
Classification Thickness (mm) Ulceration Status/Mitoses 
Tis NA NA 
T1 ≤ 1.00 
a: without ulceration and 
mitoses < 1/mm² 
b:  with ulceration or 
mitoses > 1/mm² 
T2 1.01-2.00 
a: without ulceration 
b: with ulceration 
T3 2.01-4.00 
a: without ulceration 
b: with ulceration 
T4 > 4.00 
a: without ulceration 
b: with ulceration 
 Number of metastatic nodes Nodal metastatic burden 







c: In transit 
metastases/staellites 
without metastatic nodes 
N3 
4 + metastatic nodes, or 




 Site Serum LDH 
M0 No distant metastases NA 
M1a 
Distant skin, subcutaneous, 
or nodal metastases 
Normal 
M1b Lung metastases Normal 
M1c All other visceral metastases Normal 
 Any distant metastases Elevated 
Abbreviations: T, tumor; N, node; M, metastasis; is, in situ; NA, not applicable; LDH, 
lactate deshydrogenase. 
Micrometastases are diagnosed after sentinle lymph node biopsy 
Macrometastases are defined as clinically detectable nodal metastases confirmed 
patholoically 
Table 1. TNM staging categories of cutaneous melanoma 
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 Clinical staging  Pathologic staging 
 T N M  T N M 
0 Tis N0 M0 0 Tis N0 M0 
IA T1a N0 M0 IA T1a N0 M0 
IB T1b N0 M0 IB T1b N0 M0 
 T2a N0 M0  T2a N0 M0 
IIA T2b N0 M0 IIA T2b N0 M0 
 T3a N0 M0  T3a N0 M0 
IIB T3b N0 M0 IIB T3b N0 M0 
 T4a N0 M0  T4a N0 M0 
IIC T4b N0 M0 IIC T4b N0 M0 
III Any T N > N0 M0 IIIA T1-4a N1a M0 
     T1-4a N2a M0 
    IIIB T1-4b N1a M0 
     T1-4b N2a M0 
     T1-4a N1b M0 
     T1-4a N2b M0 
     T1-4a N2c M0 
    IIIC T1-4b N1b M0 
     T1-4b N2b M0 
     T1-4b N2c M0 
     Any T N3 M0 
IV Any T Any N M1 IV Any T Any N M1 
Clinical staging includes microstaging of the primary melanoma and clinical/radiologic 
evaluation for metastases. By convention, it should be used after complete excision of the 
primary melanoma with clinical assessment for regional and distant metastases. 
Pathologic staging includes microstaging of the primary melanoma and pathologic 
information about the regional lymph nodes after partial (IE, sentinel node biopsy) or 
complete lymphadnectomy. Pathologic stage 0 or stage IA patients are the exception; they 
do not require pathologic evaluation of their lymph nodes. 
Table 2. Anatomic stage groupings for cutaneous melanoma 
1.2 Breslow index 
Among the aforementioned pathologic features to be determined in a histopathologic report 
of a melanoma diagnosis, tumour thickness also mentioned as Breslow index, is the basic 
criterion for staging a melanoma, once malignancy is confirmed. 
1.2.1 Definition of Breslow index 
By means of an ocular micrometer, the maximal thickness of the lesion is measured in 
several slides from the top of the granular cell layer to the deepest point of invasion. If the 
lesion is ulcerated, the ulcer base over the deepest point of invasion is used rather than the 
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1.2.2 Breslow index plays several roles in melanoma management 
As soon as in 1970, Alexander Breslow proposed tumour thickness as a valuable tool in 
prognosing patients’ survival as well as in selecting patients for prophylactic lymph node 
dissection (Breslow 1970). Breslow index is also used for recommendations of melanoma 
excision margins (Lens, Nathan et al. 2007). 
1.2.2.1 Breslow index as a prognostic factor 
Melanoma prognosis is based on several clinical and histopathological criteria (Tichy, 
Ditrichova et al. 2007). As seen in Table 2, the most significant and independant one is 
Breslow index. In 1975, Breslow explains that a serious problem in using Clark's levels of 
invasion as a prognostic factor is the difficulty in differentiating between an advanced level 
II and a level III lesion as the difference is somewhat subjective unless instruction was given 
by Dr. Clark himself. By contrast, measurement of tumor thickness is objective, and good 
agreement among pathologists is to be expected (Breslow 1975). Last recommendations by 
the AJCC mention that for thinnest melanomas (i.e. Breslow index < 1 mm), the mitotic rate 
histologically defined as mitoses per mm² replaces Clark level for defining T1b stage 
melanomas compared to the 2002 edition of the AJCC melanoma staging system.  
1.2.2.2 Breslow index as the determination factor of excision margins 
The primary treatment of melanoma is surgical excision. An excisional biopsy is preferred, 
both to give the dermatopathologist/pathologist an optimal specimen and to allow 
evaluation of the excision margins for residual tumour. Incisional biopsies should not be 
performed when an excisional biopsy is technically possible. The definitive surgical excision 
should be performed with safety margins preferentially within 4–6 weeks after initial 
diagnosis. The recommendations mentioned in table 3 are consistent with the evidence that 
smaller excision margins are appropriate; the values given in table 3 are in concordance with 
the American and Australian recommendations. The current recommendations are based on 
both prospective, randomised studies and international consensus conferences. There are 
limited data to suggest that margin has an effect on loco-regional recurrence, but there are 
no data to support an impact of margin on survival (Garbe, Peris et al. 2009). 
 
Tumour thickness (Breslow index) Excision margin (cm) 
In situ 0.5 
≤ 2 mm 1 
> 2 cm 2 
Table 3. Recommended excision margins of melanomas 
1.2.2.3 Breslow index as the primary predictive factor of sentinel lymph node status 
Sentinel Lymph Node Biopsy (SLNB) is a minimally invasive technique developed to identify 
patients with nodal metastases and who could be candidates for complete lymph node 
dissection (Johnson, Sondak et al. 2006). A positive SLNB has been shown to be the best 
predictor of recurrence and survival in patients with clinically node-negative cutaneous 
melanoma (Wagner, Ranieri et al. 2003). Patient mean charges for SLNB and wide excision 
alone respectively are $12,193 and $1,466 (Agnese, Abdessalam et al. 2003). In the Multicenter 
Selective Lymphadenectomy Trial, an overall complication rate of 10% after lymphatic 
mapping and sentinel lymph node biopsy was reported (46% wound infection) (Cascinelli, 
Bombardieri et al. 2006). Allergic reactions to the blue dye have also been rarely reported 
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(Daley, Norman et al. 2004). Thus selection of patients for SLNB is an area of debate. Breslow 
index is a validated, reproducible factor that is predictive of SLN status, and it currently is 
the primary criterion used to determine whether or not SLN biopsy is considered (Paek, 
Griffith et al. 2007). National Comprehensive Cancer Network recommendations are to 
perform SLNB on appropriate patients defined as patients with stage IA thin melanomas 
(1.0 mm or less) with adverse prognostic factors such as thickness over 0.75 mm, positive 
deep margins, lymphovascular invasion, or young patient age. Ranieri et al (Ranieri, 
Wagner et al. 2006) mention Breslow thickness, Clark level of invasion and mitotic index as 
statistically significant criterions in disease subset <1 mm in predicting the SLNB result. In 
the disease subset .75 to 1.0 mm thick, only mitotic index was predictive of the SLNB result. 
2. Interest of non-invasive determination of Breslow index 
The objective of this current chapter is to review the techniques whose potential to non-
invasively determine Breslow index has been studied. Basic and technical principles of each 
technique will be mentioned as well as their accuracy in the determination of a factor whose 
importance in the clinical management of melanoma is so important as previously 
demonstrated. Currently Breslow index is measured by the anatomo-pathologist after 
incisional or excisional biopsy of the suspected lesion. So why non invasive determination of 
Breslow index would be of utmost clinical value? 
The accuracy of a biopsy depends on the expertise of the clinician. If a decision not to do a 
complete excision is made, partial biopsy specimens are usually taken from the most deeply 
pigmented, elevated, nodular, or other clinically suspect area. However, as a result of 
sampling error or a lack of correlation between the clinical and histological features, the 
portion biopsied may not be the most histologically representative portion of the lesion (Ng, 
Barzilai et al. 2003). Ng et al (Ng, Barzilai et al. 2003) found that in 95 of 108 initial shave or 
punch biopsies (88%), the physicians’ clinical assessment of the melanoma for biopsy was 
accurate. A majority (84.8%) of the latter physicians were dermatologists with a median time 
of 11 years of post residency clinical experience. Khorshid et al found that general 
practitioners made a confident clinical diagnosis of melanoma 17% of the time and that the 
rate of incomplete excisions was significantly higher among general practioners (Khorshid, 
Pinney et al. 1998). 
Moreover SLNB can be affected by the surgical resection of the primary lesion. When the 
primary lesion is intact or excised with a narrow margin, the lymphatic vessels draining the 
lesion remain intact, making SLNB a highly accurate method of identifying the lymph node 
basins at risk and the lymph nodes most likely to harbor metastatic disease. Although SLNB 
and wide local excision (WLE) are usually performed during a single operation, some 
patients are referred for SLN identification after a WLE has been performed. There is 
concern that the patterns of afferent lymphatic flow from a primary tumour site in this 
setting may be altered as a result of a WLE’s disruption of the lymphatic vessels. This 
disruption may negatively impact the ability to identify SLNs and/or render SLNB less 
accurate in reflecting the pathologic status of the draining lymph node basins in these 
patients, since the remaining drainage pathways identified may no longer represent the 
primary tumour’s actual drainage. Theoretically, SLNB could misidentify the true SLNs, 
leaving patients at greater risk for lymph node basin failure and denying some patients the 
potential benefit of early therapeutic lymph node dissection and early adjuvant therapy 
(Gannon, Rousseau et al. 2006). Studies are controversial on whether or not prior WLE 
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impairs SLN status. Lesion location bias and rotational flap closure have been proposed as 
explanations to such controversies (McCready, Ghazarian et al. 2001; Gannon, Rousseau et 
al. 2006). 
In conclusion to such clinical problems associated with invasive determination of Breslow 
index, we think that non-invasive determination of Breslow index would be a great advance 
in every day clinical management of melanoma. What techniques have been proposed to do 
so? 
3. Non-invasive determination of Breslow index 
Techniques for non-invasive Breslow determination use either mechanical or electromagnetic 
waves. A wave is the propagation of a perturbation inducing reversible variations of local 
physical properties. It transports energy but no matter. Ultrasounds and optical waves are 
used mainly because of their innocuousness.  
In the next paragraphs, ultrasonography then several optical techniques will be developed. 
Basic physical principles of each type of wave interaction with skin will be described then 
accuracy of Breslow index determination by such techniques will be given. One paragraph 
will talk about techniques that have already given promising results in a clinical 
environment in vivo, namely ultrasonography and dermoscopy. A second paragraph will 
address Diffuse Reflectance Spectroscopy (DRS) that has been tested on phantoms 
mimicking melanoma. A third paragraph will talk about two techniques that have given 
preliminary results on potential Breslow index determination: the first one, infrared 
microimaging, performed on fixed and paraffin-embedded tissues (i.e. after excision of the 
tumour) and the second one, photoacoustic microscopy, performed in vivo on mice on which 
melanoma human cells were xenografted. Finally a fourth paragraph will address the topic 
of two techniques that have already shown excellent results in the area of skin thickness 
determination but for which no studied has yet been carried out to determine Breslow 
thickness although they do have the potential of doing so at least for thin melanoma (<1 
mm): Optical Coherent Tomography (OCT) and Confocal Microscopy (CM). 
3.1 In vivo techniques already available in clinics 
3.1.1 Ultrasonography 
3.1.1.1 Technical basis 
Ultrasound is a longitudinal mechanical pressure wave. It is characterized by its velocity 
which has been reported for human skin, ranging from 1498 up to 1710 m/s (Agache and 
Humbert 2004). According to the information reported by Weichenthal (Weichenthal, Mohr 
et al. 2001), in the tissue of human skin affected by melanoma the ultrasound velocity 
deviates only by 1% from the value obtained in the case of healthy skin. If the ultrasound 
velocity is known, it is possible to calculate skin and/or tumour thickness in vivo, from the 
expression l = v . t/2, where t is the time separating echoes generated by the external 
medium-epidermis interface and the dermis-subcutis interface, and v is ultrasonic velocity 
(Jasaitiene, Valiukeviciene et al. 2011). 
3.1.1.2 Ultrasounds and skin interactions 
Ultrasounds are characterized by frequencies between 20 kHz and 20 MHz. The choice of 
frequency impacts maximum penetration depth as well as axial resolution. Indeed ultrasound 
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attenuation A is proportional to frequency f: A = A0 . fβ (β ~ 1 for soft tissues). Maximum 
thickness of human skin is 300 μm for epidermis and 2.5 mm for dermis (Moore, Lunt et al. 
2003). Axial resolution λ is calculated as follows: λ = v / f. In the next paragraph several 
studies use different ultrasound frequencies that therefore influence measurements accuracy 
of Breslow index. To give the reader a rough idea of such possible axial resolutions: 79 μm 
and 21 μm using 20 MHz and 75 MHz ultrasounds respectively. 
3.1.1.3 Non-invasive determination of Breslow index using ultrasonography (Guitera, Li 
et al. 2008; Machet, Belot et al. 2009; Vilana, Puig et al. 2009; Kaikaris, Samsanavicius et al. 
2010) 
In most studies evaluating sonography for measuring cutaneous lesions in the published 
literature, investigators used frequencies of 20 MHz or higher. However 20-MHz scanners 
are not available in many clinics or dermatology practices. But such studies using 10 MHz 
are as important as studies using 75 MHz ultrasounds even though they do not have the 
same goal. On the one hand, 10-MHz ultrasonography aims at distinguishing between thick 
(> 1 mm) and thin (< 1 mm) melanomas. Such a boundary is important in every day clinical 
practice for determining safety margins and for indication for SLNB in a potential one-time 
procedure; on the other hand, by increasing transducer frequency and as it increases axial 
resolution, technological advances can be expected to improve the accuracy of sonometric 
measurements of melanoma thinner than 1 mm. Another piece of information to keep in 
mind is that maximum penetration depth of 20- and 100-MHz ultrasounds is 7.6 mm and 1.5 
mm respectively. Therefore, highest ultrasound frequencies may not be used to estimate 
melanomas thicker than 1.5 mm. 
In order to evaluate the ability of ultrasonography to determine Breslow index, sonometric 
measurements are compared to the current gold-standard type of measurement: histometry, 
following a methodology described in previous paragraphs. 
Correlation between sonometric and histometric results shows the relationship between 
investigation methods but not the sameness of separate examination results. Thus Bland and 
Altman (Bland and Altman 1986) created the Band and Altman graph that includes the 
numerical identity between the test results of two different methods. It uses the differences 
between the paired measurements and is suggested to be a more useful indication as to 
whether one method can be a valid substitution for another. 
Melanomas generally appear as solid homogeneous hypoechoic lesions and naevi have a 
more irregular distributed internal echo. Dermis appears hyperechoic. When the tumours 
extend beyond the dermis-subcutis border, the demarcation may become difficult because 
apart from connective tissue septae, the subcutaneous fatty tissue is also hypoechoic. Also 
when lesions are that thin that they do not infiltrate the dermis, they can be invisible to 
ultrasonography. Other causes of discrepancies between sonometry and histometry are: 
- Nevus cell collection beneath the melanoma, 
- Hyperkeratosis that may cause overestimation, 
- Anatomical location: strongest correlation for head and neck regions and 
overestimation for ear, genitalia or nail, 
- Histological type: strongest correlation for nodular and superficial melanomas, 
- Peritumoral reaction such as inflammatory infiltrate, fibrosis, neovascularisation and 
elastosis in the surrounding dermis are believed to overestimate thickness when 
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- Actinic damage (such as on face) resulting in subepidermal hypoechoic band result in 
overestimation. 
General overestimation of sonometric results compared to histometric results may also be 
due to excision processing: 
- Natural shrinkage of the skin occurring after excision, particularly evident for the 
dermis, and 
- Routine histology using conventional formalin-paraffin processing frequently distorts 
the anatomy of the horny layer and may result in artefacts including shrinkage of the 
tissue. 
Table 4 gives three examples of published results of comparison between histometry and 
sonometry in evaluating Breslow index. 
 
Reference Ultrasound frequency 
Mean difference between 
histometry and sonometry 
(Pellacani and Seidenari 
2003) 
20 MHz 6 μm 
(Gambichler, Moussa et al. 
2007) 
20 MHz vs. 100 MHz 71 μm vs. 16.9 μm 
(Vilana, Puig et al. 2009) 
14 MHz 
< 1 mm vs. < 2 mm 




Table 4. Mean difference between histometric and sonometric measurements of melanoma 
thickness 
3.1.1.4 Conclusion 
The use of higher transducer frequencies (75-100 MHz) may further improve not only 
thickness measurements (particularly for melanomas < 1 mm) but also differentiate between 
malignant and benign melanocytic lesions. However limited availability of the high 
frequency ultrasound devices still precludes their widespread use. Rallan (Rallan, Dickson 
et al. 2006; Rallan, Bush et al. 2007) report that ultrasound imaging may help to differentiate 
benign pigmented lesions such as seborrheic keratosis, pigmented basal cell carcinoma or 
dermal nevus from melanoma but not atypical nevi from thin melanoma which is the main 
problem. Since accurate diagnosis of melanoma is mandatory before clinical management 
according to Breslow index determination, Doppler tool may be used to detect abnormal 
vascularisation which may help for differential diagnosis. Contrast agents may be used as 
well as other types of techniques based on light and that will be described in the next 
paragraphs: dermoscopy or confocal microscopy. 
3.1.2 Dermoscopy 
3.1.2.1 Light-skin interactions 
Light is defined as electromagnetic waves that can be detected by human eye. Therefore 
light commonly includes electromagnetic waves whose wavelengths are between 380 and 
760 nm long. Oftentimes ultraviolet (UV) as well as infrared (IR) radiation are included into 
so-called “light”. Although such radiations are not visible they behave the same way as light 
from a geometrical optics point of view. As seen in Table 5, the International Commission on 
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Illumination (Commission Internationale de l’Eclairage, CIE) defines colours as spectral ranges 
within the light bandwidth. 
 
Colours Spectral ranges (nm) 
UVC 250 – 280 
UVB 280 – 315 
UVA 315 – 380 
Violet 380 – 439 
Blue 439 – 498 
Green 498 – 568 
Yellow 568 – 592 
Orange 592 – 631 
Red 631 – 760 
Infrared 760 – 25,000 
Table 5. Spectral ranges defined by the International Commission on Illumination within the 
optical bandwidth 
Skin is an optically inhomogeneous and absorbing media whose average refractive index is 
higher than that of air. This is responsible for partial reflection of the radiation at the tissue / 
air interface. Reflection from the surface of any flat material, where the angle of reflection is 
equal to the angle of incidence, is known as “specular reflection”. When the reflective 
surface is a bulk material, the reflection spectrum is governed by the Fresnel equations: as a 
result this type of reflection has been called Fresnel reflection (Griffiths and Haseth 2007). 
Bulk scattering is a major cause of dispersion of approximately 5 - 7% of the incident 
radiation (over the entire spectrum) in the backward direction.  
The remaining part of the radiation penetrates the tissue. Multiple scattering and absorption 
are responsible for radiation broadening and decay as it travels through the tissue. 
Two types of subsurface scattering occur within skin layers: Mie and Rayleigh scattering 
(Jacques 1996). 
The first and outermost section of human skin is the stratum corneum, which is a stratified 
structure approximately 10 – 20 μm thick mainly composed of dead cells, called corneocytes, 
embedded in a particular lipid matrix. Light absorption is low in this tissue, with the 
amount of transmitted light being relatively uniform in the visible region of the light 
spectrum. 
The epidermis is a 30 – 300 μm thick structure in which four layers can be distinguished 
from a cellular point of view. From bottom to top, keratinocytes start from undifferenciated 
cells (unipotent stem cells) to become specialized cells (corneocytes). The four layers each 
correspond to a different maturation step of keratinocytes along their ascension to the top: 
- stratum basale includes unipotent stem cells that are each responsible for the renewal of 
a portion of the epidermis; they undergo asymmetric division: each stem cell gives rise 
to one daughter stem cell and another daughter cell that undergoes differentiation in 
starting its way towards the skin surface; besides keratinocytes stratum basale includes 
melanocytes but such cells’ main role in light – skin interaction will be in explaining 
light absorption; 
- stratum spinosum are given this name because keratinocytes look like spines, 
- stratum granulosum; this name was given because of the keratin dots within the 
keratinocytes cytoplasm, and 
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- stratum lucidum that can be distinguished in thick skin (e.g. palm) composed of 
transparent epidermal cells with traces of nuclei. 
The epidermis propagates and absorbs light. The absorption properties come from a natural 
chromophore: melanin produced by melanocytes then transmitted to melanosomes that lie 
within the stratum spinosum. Typically the volume fraction of the epidermis occupied by 
melanosomes varies from 1.3% (Fitzpatrick skin type I) to 43% (Fitzpatrick skin type VI). 
The dermis is a 600 – 2,500 μm thick structure which also propagates and absorbs light. It 
can be divided into two layers based on histological appearance: 
- papillary dermis, and 
- reticular dermis. 
These layers are composed of connective tissue made of type I and III collagen and elastin, 
with nerves and blood vessels. Haemoglobin is a natural chromophore found in blood cells. 
In the arteries and in veins, 90-95% and 47% respectively of haemoglobin is oxygenated. 
These two types of haemoglobin, namely oxygenated and deoxygenated haemoglobin, have 
slightly different absorption spectra. Two other blood-derived pigments are found in the 
dermis: bilirubine and β–carotene (that may be found in the epidermis as well). 
The hypodermis is a subcutaneous adipose tissue characterized by a negligible absorption of 
light (Technical report of A. Krishnaswamy and G.V.G. Baranowski, A study on skin optics, 
CS-2004-01). 
3.1.2.2 Dermoscopy 
Dermoscopy, also called dermatoscopy, epiluminescence microscopy or skin surface 
microscopy, was developed in the 1990s in order to augment the early diagnosis of 
melanoma. First technologies allowed the observer to examine pigmented skin lesions 
covered by a drop of oil and a glass slide through a stereo microscope. Then dermoscopy 
developed into a hand-held lighted magnifier to analyze skin lesions by observing newly 
defined and descriptively named subsurface structures: eg, dots, streaks, veils, and 
networks. The initial instruments used an oil or alcohol interface to decrease light reflection, 
refraction, and diffraction. This made the epidermis essentially translucent and allowed in 
vivo visualization of subsurface anatomic structures of the epidermis and papillary dermis 
that are otherwise not discernable to the unaided eye. Dermoscopes usually facilitate a 10-
fold magnification of the skin. Newer instruments make the process easier to use by using 
cross-polarizing light filters which eliminate the need for oil or alcohol. Computer-based 
polarized light dermoscopes were lately commercialized (Rigel, Russak et al. 2010). 
3.1.2.3. Breslow index determination based on dermoscopy 
As described on the dermoscopy.org web site (Dermoscopy), dermoscopic criteria for the in 
vivo detection of melanoma depth are: 
- pigment network: its occurrence inversely correlates with melanoma thickness, 
- blue-whitish veil corresponds to an acanthotic epidermis with focal hypergranulosis 
above sheets of heavily pigmented melanocytes in the dermis. A blue-whitish veil is 
observed in 78% of melanomas > 0.75 mm thick and only in 21% of melanomas < 0.76 
mm thick. 
- Atypical vascular patterns are defined as vascular structures irregularly distributed 
throughout a given melanoma. Under this definition, atypical vascular patterns are seen 
in 66% of melanomas > 0.75 mm thick and only in 14% of melanomas < 0.76 mm thick. 
Combinations of dermoscopic criteria along with clinical criteria such as clinical elevation, 
assessed as flat, palpable, or nodular and largest diameter have subsequently been proven to 
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increase accuracy in the preoperative evaluation of melanoma thickness. By subdividing all 
melanomas into two groups of less than, or greater than, 0.75 mm thickness, these 
combinations allow correct thickness predictions in 93% of thin non-metastazing (TnM) 
melanomas and 82% of melanomas > 0.75 mm for a total of 89% of cases (Argenziano, 
Fabbrocini et al. 1999). Carli et al showed that a 6.8 dermatoscopic score allowed a 79%- 
positive predictive value for classification of melanomas into two groups of Breslow index 
less than or greater than 0.55 mm (Carli, de Giorgi et al. 2000). However Haenssle (Haenssle, 
Korpas et al. 2009) chose to use the 7-point checklist as this algorithm can be learned and 
applied more easily by nonexperts (e.g., residents in dermatology) while still allowing a 
high sensitivity. They carried out a 10 year–prospective clinical study on 688 patients at 
increased melanoma risk detecting a total of 127 melanomas. This study showed no 
statistical significance in lower 7-point checklist score in melanoma in situ compared to 
invasive melanoma. 
3.2 Diffuse Reflectance Spectroscopy (DRS) 
Optical spectroscopy methods are based on interactions of light with biological tissues. 
During the past twenty years, Diffuse Reflectance (DR) and AutoFluorescence (AF) 
spectroscopies have been the most investigated spectroscopy modalities. DR spectroscopy is 
based on elastic scattering of photons within biological tissues. Elastic scattering is caused 
by variations in the refractive index of small particles in the medium, resulting in dispersion 
of light in all directions, without loss of energy, i.e. no wavelength shift between incident 
and reflected light. Different types and sizes of scattering centres can be found within the  
 
 
Fig. 1. Principle of axial resolution obtained thanks to several collecting optical fibres at 
several distances from the excitation optical fibre in Diffuse Reflectance Spectroscopy 
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tissue: collagen fibres, cellular membranes and subcellular structures (nuclei, mitochondria). 
As seen in figure 1, in order to use DR spectroscopy for Breslow index determination, 
Amouroux (Amouroux, Blondel et al. 2008) used several collecting optical fibres at different 
distances from the excitation optical fibre. Because of numerical aperture of optical fibres, 
the probing depth (different from the penetration depth) increases with inter-fibre distance. 
Of course this has limitation due to decreasing intensity with inter-fibre increase. It has been 
reported that excitations in the wavelength range 337 – 400 nm allow for probing depth of 
225 – 250 μm in skin tissues with inter-fibres distance of 250 μm (Katika and Pilon 2006). 
To our knowledge, the only study on Breslow index determination using DRS was carried 
out on phantoms as a preliminary study prior to a clinical trial. Two-layer phantoms 
mimicking dermis (6.3 mm thick) for the bottom layer and melanoma (2, 3, 4, 5 and 6 mm) 
for the upper layer were made of gelatine as a solid 3D-matrix, intralipids for the scattering 
properties and coffee for the absorbing properties of melanoma. Based on the slopes of 
decreasing intensities recorded at the 5 different inter-fibre distances (271, 536, 834, 1076 and 
1341 μm), the five different top layers’ thicknesses could be discriminated. Further works 
need to discriminate thicknesses less than 1 mm which is at stake in clinical practice: 0.5, 1 
and 1.5 mm for instance. 
3.3 Techniques that have shown preliminary results 
3.3.1 Infrared-microimaging 
Absorption and scattering (Raman) infrared vibrational spectroscopies consist in 
determining vibrational frequencies of atoms within molecules giving access to information 
on that molecule’s state and further on its environment for instance. Fourier Transform 
Infrared (FTI) spectroscopy can be performed directly on fixed and paraffin-embedded 
tissues without staining. Reports have shown the possibility to discriminate between 
melanoma and normal epidermis or between melanoma and benign nevi. In 2010, Ly (Ly, 
Cardot-Leccia et al. 2010), carried out the first study on the possibility by FTI spectroscopy 
to distinguish between the different types of melanoma and to identify IR specific signatures 
of dermatopathological parameters: ulceration, Breslow index, Clark level and number of 
mitoses per mm². In each colour-coded image, pixels assigned to the same cluster represent 
an area of similar biochemical composition, producing an automated and objective digital 
staining of the sample. Ly et al found out that only one tumour cluster was observed for 
good prognosis melanomas whereas two or three clusters were simultaneously present for 
bad prognosis melanoma. However they still could not correlate such findings to Breslow 
index, even though Breslow index can be related to prognosis. Further studies will probably 
have to be carried out in order to determine whether or not it is possible to have an 
automated Breslow index determination through FIT extracted features. Such determination 
would spare a lot of time and would avoid Breslow index misdetermination if the section of 
the excised tumour is not made along the thickest part of the tumour. 
3.3.2 Photoacoustic microscopy 
Photoacoustic is a non-invasive imaging modality for imaging biological tissue structures by 
means of laser-induced ultrasound. Structures with optical absorption, such as blood vessels 
for instance, can be imaged with the spatial resolution of ultrasound. Lateral and axial 
resolutions as well as penetration depth were reported to be 45 μm, 15 μm and 3 mm 
respectively. Oh et al report good agreement with histometric measurements of melanomas 
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obtained on mice after human melanoma cells xenografted subcutaneously (Oh, Li et al. 
2006). 
3.4 Techniques that may have the potential to be used for Breslow index 
determination 
Optical Coherence Tomography (OCT) as well as Confocal Microscopy (CM) are widely 
used techniques used for skin thicknesses (epidermis, dermis, etc.) measurements. However, 
probably because of their low penetration depth (1 mm and 0.3 mm respectively), they have 
not been studied in the context of Breslow index determination yet. But as we will see in the 
next paragraph, they could potentially address determination of thin melanomas especially 
since they provide good accuracy in differential diagnosis of pigmented skin lesions. 
3.4.1 Optical Coherence Tomography (OCT) 
Different terms are employed in the literature to specify this method on investigations: dual-
beam coherent interferometry or laser Doppler interferometry, optical coherence 
tomography (OCT) or optical coherence reflectometry. OCT is analogous to ultrasonic 
imaging, which measures the intensity of reflected infrared light rather than reflected sound 
waves from the sample. Time gating is employed so that the time for the light to be reflected 
back (or echo delay time) is used to assess the intensity of back-reflection as a function of 
depth. Unlike ultrasound, the echo time delay on the order of femtoseconds cannot be 
measured electronically due to the high speed associated with the propagation of light. 
Therefore, a time-of-flight technique has to be engaged to measure such an ultrashort time 
delay of light back-reflected from the different depth of a sample. OCT uses an optical 
interferometer illuminated by a low-coherent-light source so solve this problem (Tuchin 
2007).  
To our knowledge, no study has yet addressed the issue of Breslow index determination 
using OCT. Only one study tried to determine OCT specific features of benign and 
malignant melanocytic skin lesions. OCT of benign nevi demonstrated correlates of typical 
histological features including the finger-shaped elongation of rete ridges and dense cell 
clusters in the dermoepidermal junction zone and/or dermis. OCT features of malignant 
melanoma were large vertically arranged icicle-shaped structures, which mainly 
corresponded to dense dermal infiltrates of melanocytes as confirmed by histology. 
However Gambichler (Gambichler, Regeniter et al. 2007) were not able to detect any 
definitive features in OCT images enabling to differentiate tumour subtypes and tumour 
stages, e.g. thin vs. thick melanomas. The latter observation is, however, not surprising 
because the penetration depth of current OCT techniques is limited to about 1 mm in highly 
turbid media such as human skin. However, the greatest challenge in the diagnosis of 
malignant melanoma represents the discrimination of early melanomas (<1 mm) from 
benign nevi, for example. OCT techniques that provide a depth of penetration of 
approximately 1 mm potentially address the aforementioned diagnostic issue. 
3.4.2 Confocal microscopy (CM) 
Confocal Scanning Laser Microscopy (CLSM) is a non-invasive technique that provides real-
time in vivo imaging of skin lesions at variable depths in horizontal planes equivalent to the 
resolution of conventional microscopes. With this technique, a beam splitter separates the 
light mixture from the laser by allowing only laser light to pass through while reflecting 
www.intechopen.com
 
Current Management of Malignant Melanoma 
 
42 
fluorescence light onto a detection apparatus with a pinhole-sized spatial filter. Scattered 
photons can be selected from a given volume. The great advantage of a confocal microscope 
is that axial resolution is enhanced, which results in the “optical sectioning” capability. 
Reflectance Confocal Microscopy (RCM) allows a higher resolution analysis of dermoscopic 
features than does CLSM but is more technically sensitive and expensive to use and is not as 
effective in analyzing deeper structures.  RCM can assess microanatomical structures to a 
depth of only 300 μm (Tuchin 2007; Rigel, Russak et al. 2010).  
In a study aiming at evaluating RCM as a secondary source of information for pigmented 
skin lesions after clinical (naked eye) and dermoscopic evaluations, Guitera (Guitera, 
Pellacani et al. 2009) found out RCM examination was particularly accurate for light-colored 
lesions. This is of utmost medical value since such lesions are well-known clinical and 
dermoscopy challenges. RCM helps improve specificity thus dramatically reducing the rate 
of benign lesions excisions by 23% for the current study. A 98%-sensitivity is reached when 
clinically suspicious lesions were assessed for diagnosis by combining dermoscopy and 
RCM. 
4. Conclusion 
Non-invasive Breslow index determination would allow one-time procedure for melanoma 
clinical management which would be of utmost medical interest for several reasons: 
unimpaired sentinel lymph node status, low morbidity, pain and stress associated to 
surgical excision margins. However, as explained throughout the current chapter, such a 
determination requires melanoma diagnosis prior to Breslow determination. As a result, all 
techniques reported in this chapter (based on ultrasounds, optical waves or both), not only 
demonstrate their ability to determine Breslow thickness but also how they increase 
diagnosis accuracy. Therefore, as previously mentioned (studies combining confocal 
microscopy and dermoscopy or ultrasounds and optical microscopy), the key for an optimal 
melanoma management in a clinical environment might be to combine different of the 
aforementioned techniques and see which combination would allow not only an accurate 
melanoma diagnosis but also a precise Breslow index determination. Studies should now be 
carried out in this philosophy. 
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